Guidelines Call for Breastfeeding Exclusion without Actual Milk Allergy Diagnosis

April 14, 2020


A new summary of recent cow's milk allergy guidelines show conlficting consensus on identifying and caring for infantile allergic symptoms.

Tezepelumab for Atopic Diseases

April 10, 2020


Clinical investigator and allergist Jonathan Corren, MD, shares insight on the TSLP inhibitor.

Higher Mortality Rate for Celiac Disease Patients

April 09, 2020


New data shows higher rates of cancer and cardiovascular disease deaths for patients with celiac disease.

Add-On Dupilumab Significantly Clears Pediatric Eczema Skin

April 05, 2020


New pivotal phase 3 findings support an upcoming sBLA for the IL4 and IL13-targeting agent.

Patients Receiving Glucocorticoids at Higher Risk During COVID-19 Pandemic

April 03, 2020


Discussing an editorial in the Journal of Clinical Endocrinology & Metabolism with journal editor in chief Paul Stewart, MD.

House Call: Athlete Testing for COVID-19

March 25, 2020


What effect may professional athletes receiving asymptomatic tests have on the public perception of the coronavirus?

Follow-Up Viaskin Peanut Patch Data Shows Cross-Contamination Benefit

March 23, 2020


The three-year study represents the largest long-term kinetic immunotherapy trial.

FDA Adds Boxed Warning to Montelukast Label

March 05, 2020


The label update comes after findings have repeatedly shown an associated risk of neuropsychiatric events.

Lebrikizumab Clears Eczema Skin Rapidly, Safely

March 04, 2020


New data evidences yet another IL-13 targeting biologic for atopic dermatitis.

FDA Approves Two Prescription Allergy Eye Drops for OTC Use

February 17, 2020


The FDA announced the switch of the 2 eyedrops, which took place through their RX-to-OTC program.